Rifamycin mycelial dreg (RMD) is a biological waste, and its residual rifamycin (RIF) is potentially harmful to both the environment and human health. In this work, thermally activated persulfate (PDS) oxidative degradation of RIF in RMD was developed for the first time. The effects of reaction temperature, initial PDS concentration, and pH on RIF degradation in RMD were investigated, and the treatment conditions were optimized using response surface methodology (RSM). The results showed that 90 °C, 50 mg/g PDS, and pH = 5.3 were the optimal pretreatment conditions, and 100% degradation efficiency of RIF (734 mg/kg) was achieved. SEM and FTIR analyses confirmed that the RIF was destroyed and decomposed after the oxidation reaction. The possible degradation pathways of RIF in the thermally activated PDS system were discussed through HPLC/MS and ESR analyses. The intermediate product was identified, and the toxicity of the final product was predicted to be low or nontoxic. In this work, a degradation pathway of RMD was proposed by activating persulfate, which facilitates subsequent resource utilization and provides meaningful guidance for the practical treatment of antibiotic mycelium residue (AMR).
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.scitotenv.2022.153229 | DOI Listing |
Sci Total Environ
August 2022
Qingdao Engineering Research Center for Rural Environment, College of Resources and Environment, Qingdao Agricultural University, Qingdao 266109, China. Electronic address:
Sci Total Environ
May 2022
Qingdao Engineering Research Center for Rural Environment, College of Resources and Environment, Qingdao Agricultural University, Qingdao 266109, China. Electronic address:
Rifamycin mycelial dreg (RMD) is a biological waste, and its residual rifamycin (RIF) is potentially harmful to both the environment and human health. In this work, thermally activated persulfate (PDS) oxidative degradation of RIF in RMD was developed for the first time. The effects of reaction temperature, initial PDS concentration, and pH on RIF degradation in RMD were investigated, and the treatment conditions were optimized using response surface methodology (RSM).
View Article and Find Full Text PDFTwo types of apparatus recommended for drying paste-like products, i.e. a continuous-belt film drier and a spouting-bed drier were tested to choose a process for drying mycelial waste.
View Article and Find Full Text PDFClin Infect Dis
January 1992
Department of Medicine, Santa Clara Valley Medical Center, San Jose, California 95128.
Twelve patients receiving therapy with an azole agent (ketoconazole, itraconazole, and/or fluconazole) for systemic mycoses experienced drug interactions with rifampin, phenytoin, and/or carbamazepine resulting in substantial decreases in azole concentrations in serum. All four patients receiving azoles and concurrent phenytoin and/or carbamazepine failed to respond to treatment or suffered a relapse of their fungal infection. Four of five patients with cryptococcosis who received itraconazole and rifampin responded despite decreases in their serum itraconazole concentrations; synergy between itraconazole and rifampin was documented by in vitro analysis of inhibition and of killing of Cryptococcus neoformans isolates from all patients receiving this combination.
View Article and Find Full Text PDFAuthors emphasize the pathogenetic importance of fungous dimorphism and its consequence in the usefulness of antimycotic drugs. For the study of drugs' activity on C. albicans, two models for the evaluation on yeast or mycelial form were developed.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!